Cargando…
Peptides to Overcome the Limitations of Current Anticancer and Antimicrobial Nanotherapies
Biomedical research devotes a huge effort to the development of efficient non-viral nanovectors (NV) to improve the effectiveness of standard therapies. NVs should be stable, sustainable and biocompatible and enable controlled and targeted delivery of drugs. With the aim to foster the advancements o...
Autores principales: | Del Genio, Valentina, Bellavita, Rosa, Falanga, Annarita, Hervé-Aubert, Katel, Chourpa, Igor, Galdiero, Stefania |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230615/ https://www.ncbi.nlm.nih.gov/pubmed/35745807 http://dx.doi.org/10.3390/pharmaceutics14061235 |
Ejemplares similares
-
Design and Validation of Nanofibers Made of Self-Assembled Peptides to Become Multifunctional Stimuli-Sensitive Nanovectors of Anticancer Drug Doxorubicin
por: Del Genio, Valentina, et al.
Publicado: (2022) -
Glycosylation and Lipidation Strategies: Approaches for Improving Antimicrobial Peptide Efficacy
por: Bellavita, Rosa, et al.
Publicado: (2023) -
A New Hope: Self-Assembling Peptides with Antimicrobial Activity
por: Lombardi, Lucia, et al.
Publicado: (2019) -
Peptides and Dendrimers: How to Combat Viral and Bacterial Infections
por: Falanga, Annarita, et al.
Publicado: (2021) -
Myxinidin-Derived Peptide against Biofilms Caused by Cystic Fibrosis Emerging Pathogens
por: Bellavita, Rosa, et al.
Publicado: (2023)